Part 10: Evaluation and Management of Pulmonary Disorders
Welcome to Last Minute Lecture.
This free chapter overview is designed to help students review and understand key concepts.
These summaries supplement not replaced the original textbook and may not be redistributed or resold.
For complete coverage, always consult the official text.
Welcome back to the Last Minute Lecture team.
So, if you are a student prepping for your clinicals or, you know, maybe getting ready for exams, you are in exactly the right place.
Yeah, absolutely.
We're so glad you're joining us today.
Because today's deep dive is a total masterclass.
We are unpacking the evaluation and management of pulmonary disorders.
Right, which covers chapters 84 to 97 of primary care into professional collaborative practice, the sixth edition.
Exactly.
And the mission for this deep dive is to not just read facts at you.
You already know the basics, right?
Like, you know what an alveolus is.
I mean, I hope so.
Seriously, we want to act as your personal tutors today.
Yeah, we're going to break down the pathophysiology, the clinical reasoning, and like the team -based care coordination.
Because in primary care, you have to understand the how and the why behind these complex diagnostic tables.
It's not just about memorizing.
Right.
It's about real world decisions.
Yeah.
So, let's just dive right into section one, acute bronchitis, or the chest cold conundrum.
Oh, such a classic primary care trap.
It really is.
I mean, we see over 70 % of patients with acute bronchitis walking out with an antibiotic prescription.
Which is wild because the clinical data clearly shows that less than 10 % of these cases are actually bacterial.
Wait, less than 10 %?
Yeah, it's almost entirely viral.
So, we have this massive disconnect between the evidence and what providers are actually doing.
That's crazy.
Okay, so clinically, how do you define it?
It's an acute self -limited inflammation of the trachea and major bronchi, right?
Exactly.
Yeah.
Usually lasting one to three weeks.
But the key here is that it's without consolidation.
Right, meaning we are explicitly ruling out pneumonia.
Right.
And epidemiologically, it's just a massive burden.
Quafing accounts for about 5 % of the US population seeking care annually.
So, why are they caulking so much?
I mean, what's actually happening in the and then actual epithelial damage from the virus.
But wait, a lot of patients, like 50 % of them, come in coughing up green or yellow mucus.
Oh, the famous purulent sputum.
Yeah.
Doesn't green or yellow mucus automatically mean we need antibiotics?
I mean, that's what everyone thinks.
I know, it's such a persistent myth.
But no, discolored sputum does not mean bacteria.
Really?
Then where does the color come from?
It's actually from your own white blood cells.
When neutrophils fight off the virus and die, they release an enzyme called myeloperoxidase.
And that enzyme is green.
Exactly.
It has a green pigment.
Oh, wow.
So, it's basically like a microscopic battlefield.
The green mucus is just the cellular debris left behind after your immune system fought the virus.
That's a perfect analogy.
It's not an active bacterial invasion at all.
So, it's a clinical diagnosis.
How do we prove it's not pneumonia without, you know, x -raying every single person?
We use specific vital sign criteria.
If their heart rate is over 100, respiratory rate over 24, or temp over 38 Celsius, then we worry.
And on physical exam, if you hear e -gophony, where an E sounds like an A or tactile fremitis, then you get the chest x -ray to rule out community acquired pneumonia.
Okay, so if their vitals are stable and the exam is clear, it's just bronchitis.
Right.
And interprofessional management here is all about resisting the urge to prescribe antibiotics.
Because of the adverse effects like C.
diff and antibiotic resistance, right?
Exactly.
The CDC actually recommends we just call it a chest cold when talking to patients.
Oh, I like that.
It sounds way less scary than acute bronchitis.
It sets the expectation that it's just a virus.
Right.
And for symptom management, we can use antitussives.
But we should definitely not be routinely giving out beta adrenergic bronchodilators like albuterol.
Right, unless they have active wheezing.
Otherwise, it doesn't help the cough.
Exactly.
Okay, so moving from a temporary chest cold to our next section.
This one is about chronic reversible inflammation,
asthma.
Yeah, asthma is a whole different ballgame.
It's a chronic inflammatory disorder causing
episodic reversible airway narrowing.
And the epidemiology here highlights some serious health disparities, doesn't it?
Absolutely.
We see significantly higher prevalence in populations living in poverty, as well as in African American, Native American, and Puerto Rican communities.
That's heartbreaking.
So getting into the path of physiology, there's this interplay of genetics and environment.
Right.
The genetic tendency is called atopy,
but the environment plays a huge role.
Speaking of the environment, the text mentions this hygiene hypothesis.
I find this fascinating.
Oh, such an interesting concept.
It basically says that playing in the dirt and catching colds from older siblings actually trains your immune system.
Yeah, it trains the TH1 immune response, which fights infections.
And if you don't get that early exposure, your immune system defaults to the TH2 pathway, which overreacts to allergens.
Exactly.
It's like your immune system gets bored because everything is too sanitized, so it starts attacking harmless stuff like dust mikes.
That is wild.
Okay, so clinical presentation.
We all know about wheezing, but what about cough variant asthma?
Right.
Sometimes a chronic cough is the only symptom.
And we also have to look out for triggers, including things like GERD.
Oh, acid reflux can trigger asthma.
Yeah, the acid can stimulate the vagus nerve and cause reflux bronchoconstriction.
I had no idea.
So how do we actually diagnose it?
Spirometry, right?
Yes.
We look at the force vital capacity, the FVC, and the FEV1.
We're looking for an obstructive pattern.
But the hallmark is reversibility, right?
Exactly.
You give them bronchodilator, wait a bit.
And if their FEV1 improves, you've got reversible airway disease, asthma.
Okay, let's do a quick tutoring moment on decoding these tables in the text.
Let's look at box 85 .1, the home treatment guidelines.
This is a crucial one for interprofessional care.
We use peak expiratory flow, or PEF, to assess severity.
Right.
So if their PEF is under 50 % of their personal best, what does that mean?
That is the red zone.
It means they need immediate medical care.
And what if it's 50 to 79 %?
That's the yellow zone.
They need quick relief.
Usually they're SAVA, which is two to six puffs spaced 20 minutes apart.
Okay, that makes sense.
Then there's box 85 .2, which is about symptom control and future risk.
Right.
So we classify their asthma as well -controlled, partly controlled, or uncontrolled.
And how do we figure that out?
We look at daytime symptoms, if they're waking up at night, and how often they need a rescue inhaler.
Okay, got it.
And then box 85 .9 gives us environmental triggers to reduce risk.
Yeah, practical things for the care team to teach, like washing linens in hot water, removing pests, and obviously stopping smoking.
Essential stuff.
So let's walk through the step -wise management.
Step one is just an as -needed sob array.
Well, actually,
guidelines are shifting.
But traditionally, yes.
Step two introduces a daily low -dose inhaled corticosteroid, or ICS.
Okay, to actually treat the inflammation, not just the symptom.
Right.
Then step three is a low -dose ICS combined with a LABA, a long -acting beta agonist.
And step four is just bumping that up to a medium or high -dose ICS with the LABA.
Exactly.
And step five is when you really need a pulmonology console for advanced therapies.
And all of this is tied to the asthma action plan with those green, yellow, and red zones we talked about.
You got it.
It's a very systematic approach.
But, you know, asthma usually causes breathlessness and tightness.
Sometimes, patients come in with overt chest pain.
And that completely changes our triage approach.
Right.
Which brings us to section three, chest pain.
This is like the ultimate primary care triage moment.
Because you have to immediately differentiate pulmonary pain from a cardiac event.
Right.
And box 86 .2 gives us the clinical signs warranting immediate transfer.
What are the big red flags?
Suspected myocardial ischemia, heart failure, a pulmonary embolism, or a significant pneumothorax.
We are looking for respiratory distress or asymmetric breath sounds.
Exactly.
Also, a widened mediastinum on imaging or pulses paradoxes greater than 10 millimeters of mercury.
Wait, pulses paradoxes.
That's when their blood pressure drops drastically when they take a breath in.
Yeah.
It means the respiratory system is working so hard, it's literally compressing the heart.
It's a huge red flag.
Okay.
But let's push back for a second.
Say you've ruled all that out.
You have a terrified patient who thinks they're having a heart attack.
But it turns out to be musculoskeletal or just GERD.
Right.
How do you reassure them?
Because they are freaking out.
Interprofessional management is key here.
You don't just say you're fine.
You validate the pain.
So you explain the actual mechanism of their pain.
Exactly.
You discuss behavioral modifications, maybe physical therapy, and give them confident reassurance.
That makes total sense.
So having ruled out immediate cardiac death, let's return to the lungs.
And probably the most frequent annoying complaint in primary care.
Yes.
Section four, chronic cough.
I always say time is the ultimate diagnostic tool here.
It really is.
The temporal definitions dictate everything.
So acute is under three weeks, subacute is three to eight weeks.
Right.
And that subacute phase is often a post -infectious cough.
Meaning their chest x -ray is normal, the infection is gone, but they are still coughing.
Yeah.
The airways are just hyper reactive.
It usually resolves on its own without much intervention.
But if it goes past eight weeks, boom, it's a chronic cough.
And that's when we have to start digging deeper.
Okay.
Let's decode box 87 .1, sputum characteristics, because this is basically tutoring on how to read mucus.
It's gross, but so helpful.
Hemoptysis, which is coughing up blood, is a huge warning sign.
What does that suggest?
Cancer?
Cancer, a pulmonary embolism, or TB.
It's an immediate red flag.
Okay.
What about pink frothy sputum?
That sounds specific.
Very specific.
That indicates pulmonary edema, usually from heart failure.
Fluid is backing up into the lungs.
Yikes.
And fetid, foul -smelling sputum.
That points to an anaerobic infection, like a lung abscess.
And finally, rust -colored sputum.
That is the classic hallmark of pneumococcal pneumonia.
Wow.
Okay.
So interpreting that tells us a lot.
And box 87 .2 outlines the indications for referral.
Right.
When the primary care team needs to call in a specialist.
So for things like asthma, TB, carcinoma, heart failure, or interstitial lung disease.
Exactly.
If it's one of those, you need a coordinated team approach.
I always compare the duration of a cough to a ticking clock.
I love that analogy.
Yeah.
The longer it ticks past eight weeks, the deeper the diagnostic toolbox we have to open.
We're talking CT scans, bronchoscopy, pH monitoring.
Yep.
You keep escalating until you find the source.
And if that chronic cough is paired with a heavy smoking history, our clinical reasoning pivots super fast to section five.
COPD.
Chronic obstructive pulmonary disease.
Right.
And the core information here is that COPD is preventable and treatable, but it is not fully reversible.
That's the huge difference between it and asthma.
Asthma versus COPD causes permanent architectural damage.
So the path of physiology is twofold, right?
It's small airway disease, which is the chronic bronchitis part.
Plus perenchymal destruction, which is the emphysema, the alveoli literally break down.
And on physical exam for advanced disease, you see some really distinct signs.
Absolutely.
The classic barrel chest because of all the trapped air.
And they often do that pursed lip breathing, right?
To create back pressure and keep the airways open.
Exactly.
You also hear diminished breath sounds.
And eventually you might see signs of right ventricular hypertrophy or core pulmonary.
Because the lungs are failing, so the heart starts failing too.
That is so tough.
It really requires aggressive interprofessional management.
Let's look at how we classify it.
Okay.
Decoding the tables again.
Box 88 .1 classifies severity by FEV1.
Right.
So stage one is mild, where their FEV1 is greater than 80%.
Stage two is moderate, between 50 and 80%.
Stage three is severe, sitting at 30 to 50%.
And stage four is very severe, meaning their FEV1 is under 30%.
That sounds awful.
It is, but FEV1 doesn't tell the whole story, which is why we also use Box 88 .2, the combined assessment.
Oh, right.
This groups patients into categories A through D.
Exactly.
It looks at their exacerbation history and their symptom burden, usually using the C at score.
So group D would be a patient with high symptoms and a history of frequent exacerbations.
Right.
And that dictates how aggressively we treat them.
Speaking of treatment, non -pharmacologic interventions are huge here.
And smoking cessation is literally the single most important intervention.
Absolutely.
The whole care team needs to emphasize that.
And then there's pulmonary rehabilitation.
I wanted to ask about that.
What exactly does pulmonary rehab do?
It's an amazing interprofessional effort.
It involves exercise training, upper and lower body strength work.
To maximize whatever lung function they have left.
Yes.
It conditions their muscles to use oxygen more efficiently, which reduces the demand on their failing lungs.
That makes total sense.
And pharmacologically, we use bronchodilators, inhaled corticosteroids, and vaccines.
Vaccines are critical.
The flu shot and the pneumococcal vaccines, PCV13 and PPSV23.
Because a simple infection could be fatal for them.
But let me ask you this.
If the lung damage is totally irreversible,
why are we prescribing all these treatments?
It's a great question.
We aren't curing the disease.
The goals are palliative and functional.
Oh, okay.
So it's about quality of life.
Exactly.
We want to reduce their daily symptoms and prevent those severe exacerbations that land them in the hospital.
We're basically just trying to give them their life back as much as possible.
Right.
And the primary symptom limiting these patients' lives is just this profound sense of breathlessness.
Which brings us perfectly to Section Stokes dyspnea.
Yes.
The subjective feeling of air hunger.
It's terrifying for the patient.
It's defined as an increased work of breathing, right?
How do we evaluate something so subjective?
Well, Table 89 .1 helps us link the patient's vocabulary to the pathology.
It's fascinating.
Okay.
So if a patient says their chest feels tight, what does that mean?
Tightness almost always points to asthma or COPD.
It's bronchoconstriction.
And what if they say they feel an increased effort to breathe?
That suggests a mechanical issue, like kyphoskeleosis or a myopathy where the muscles are weak.
Oh, interesting.
And what if they literally say they're feeling air hunger?
That is a huge red flag for a pulmonary embolism, pneumonia, or congestive heart failure.
Wow.
Just the words they use can point you in the right direction.
Exactly.
And then Table 89 .2 gives us a grading scale from 0 to 4.
Where 0 is breathless only with strenuous exercise, and 4 is they are too breathless to even leave the house.
Right.
It quantifies their impairment.
But Table 89 .3 has a crucial don't
that every provider needs to remember.
Let me guess.
Do not rely on blood gases to assess dyspnea.
Yes.
You cannot just look at an oxygen saturation of 98 % and tell the patient they are fine.
Because dyspnea is a subjective feeling.
Their brain thinks they are suffocating, even if their blood oxygen looks okay on paper.
Exactly.
You treat the symptom, not just the monitor.
So how do we diagnose the underlying cause if it's a restrictive lung process?
We use the paint mnemonic.
P -A -I -N -T.
Okay.
P is for plural.
A is alveolar.
Right.
I is interstitial.
N is neuromuscular.
And T is thoracic.
So that covers the restrictive causes.
Yes.
And when we manage these patients, especially in advanced stages, we have to know the Medicare criteria for supplemental oxygen.
Right.
Because you can't just prescribe oxygen to anyone.
The criteria are a PO2 less than 55 or PO2 under 88%.
Exactly.
And in palliative care, when they are just suffering from severe air hunger, we actually use anxiolytics and opioids.
Wait.
Opioids.
Don't those cause respiratory depression?
That feels dangerous.
It seems counterintuitive, I know.
Yeah.
But in end -of -life care, low -dose opioids actually relieve the sensation of air hunger without significantly hastening death.
Wow.
It blunts that feeling of suffocation.
That is powerful palliative care.
It really is.
It's about treating the patient's suffering.
Okay.
Shifting gears.
Dyspnea is subjective, but our next topic is terrifyingly objective for the patient.
Yeah.
Section seven.
Hemoptysis and lung cancer.
Coughing up blood is never something to ignore.
Mild cases might just be bronchitis, but severe hemoptysis needs a pulmonologist immediately.
Because lung cancer is always high on that differential.
Let's decode the cancer tables.
Okay.
We have NSCLC, non -small cell lung cancer.
Right.
Staging is crucial here.
Stage means it's small, no lymph nodes involved.
Usually, surgery is curative.
Stage two means it has spread to adjacent structures or hillar nodes, right?
Yes.
And stage three, IA or B means it's spread to the mediastinum.
That's when we debate if it's resectable or if they need chemo and radiation.
And stage IV means distant metastasis.
At that point, it's palliative.
Exactly.
Now, small cell lung cancer, SCLC,
is staged differently because it's so aggressive.
Right.
It's just limited versus extensive, isn't it?
Yep.
Limited means it fits within one radiation port, so let's say one hemothorax.
Extensive means it is spread distantly.
So for any of these, we have to watch out for clinical complications, oncologic emergencies.
Yes, like SVC syndrome,
superior vena cava syndrome.
That's where the tumor physically blocks the vein, right?
So the patient gets facial plethora, dilated neck veins.
Exactly.
It's a true emergency.
You also have to watch for brain metastasis causing seizures or hypercalcemia.
And with newer immunotherapies, we have to watch for immune -mediated toxicities, too.
Absolutely.
The interprofessional team is constantly monitoring for these.
So the text mentions performance status, like the Karnofsky or ECOG scales.
Why does that matter so much?
Because cancer treatments are highly toxic.
The oncology team uses these scales to decide if a patient's body can actually withstand aggressive chemotherapy.
Oh, I see.
So if their performance status is really low, the chemo might actually do more harm than good.
Exactly.
In those cases, focusing purely on palliative care is the most compassionate choice.
That is a tough but essential interprofessional decision.
Okay, leaving the oncology ward, let's head back to acute structural issues.
Section 8, the three P's, pleurisy, pneumonia, and pneumothorax.
Let's start with pleurisy.
It's that sharp, stabbing pain when you take a deep breath, right?
Yeah, inflammation of the pleura.
But the key thing to remember is that it's a symptom, not a standalone disease.
So it's caused by something else, like a virus or a PE, but we treat the pain with NSI's while we figure it out.
Right, exactly.
Now for pneumonia,
the epidemiological clues in the history are everything.
You mean like asking where they have been traveling?
Yes.
If they're just at a hotel or on a cruise ship, you have to think Legionella.
Oh, because of the water systems.
What if they were in the southwest U .S.?
Then you suspect coccidioids, valley fever.
And Southeast Asia.
Burkholderia, or maybe even SARS.
The history dictates the suspected pathogen before you even get lab results back.
That is true medical detective work.
Okay, our third P is pneumothorax, loss of negative intra -thoracic pressure.
Right, the lung collapses.
And there are different types.
Primary spontaneous usually happens in healthy, tall, thin people, often smokers.
While secondary spontaneous is much worse because it happens to people who already have underlying lung disease like COPD or cystic fibrosis.
Exactly.
The reserve is already so low.
There's also traumatic, from an injury, and iadrogenic, which means we caused it during a medical procedure.
And the most dangerous complication is attention pneumothorax.
I always compare this to a one -way turnstile.
That's a really good visual.
Yeah, so air gets into the pleural space when they inhale, but the tissue flap closes when they exhale.
The air can't get out.
And pressure just builds and builds, crushing the lung and the heart.
It causes obstructive shock.
It's a total emergency.
You need immediate needle aspiration or a chest tube, right?
Yes, no time to wait for an x -ray.
And patient education after a pneumothorax is super strict, like absolute avoidance of scuba diving.
Yes, and no air travel until complete resolution is confirmed by imaging.
Because the pressure changes in the cabin could make a tiny air pocket expand and pop the lung again.
Exactly.
Boyle's law in action.
Wow.
Okay, we are in the homestretch.
Section 9, three conditions bridging the pulmonary and cardiovascular systems.
Right.
Pulmonary embolism, pulmonary hypertension, and sarcoidosis.
Let's hit PE first.
A blood clot in the lungs.
You mentioned a shift in management, the PERC teams.
Yes, pulmonary embolism response teams.
It's a huge collaborative leap.
But let me push back a bit.
We have code stroke and code STEMI.
Is a PE really on that level?
Absolutely.
We call it a lung attack.
It requires that same immediate interdisciplinary coordination.
Because it puts massive strain on the right ventricle of the heart, right?
Exactly.
You need cardiology, pulmonology, and pharmacy, all working together instantly to decide on anticoagulation or thrombolytics.
That makes a lot of sense.
Okay, next is pulmonary hypertension.
Where exertional dyspnea is the main complaint, the pressure in the pulmonary arteries is just too high.
And you have to measure the pulmonary artery pressure directly to diagnose it, right?
Yes, usually with a right heart catheterization.
And management here is a true triad.
Meaning cardiology, pulmonology, and primary care all have to coordinate.
Yes, because it's so complex.
Primary care handles fluid balance and vaccines, while specialists manage the advanced vasodilators.
It's a perfect example of why interprofessional care is so vital.
Okay, last one.
Sarcoidosis.
A multi -system inflammatory disease.
Okay.
But there is one very specific presentation students need to know.
Loughgren's syndrome, right?
Yes, it's a triad, biolar lymphadenopathy on x -ray, ankle edema or arthritis,
and erythema nodosum.
Which are those painful red bumps on the shins.
Exactly.
If a patient has those three things, it has a 95 % diagnostic specificity for sarcoidosis.
Wow, so you barely even need a biopsy at that point.
Right, it's that specific.
Well, that brings us to the end of our outline.
I want to leave everyone with a final provocative thought.
Yeah, I think the biggest takeaway here is the reality of interprofessional care.
Because in primary care, you're the detective, right?
You find the clues, the travel history, the dropping FEV1, the pulses paradoxes.
But you are never acting alone.
The true art of primary care is knowing when to reassure a patient with a chest cold, when to prescribe an inhaler, and exactly when to call in the PERT team or the pulmonologist.
It's about knowing your limits and utilizing your team.
Thank you all so much for studying with the Last Minute Lecture team today.
We really hope this deep dive helped connect the textbook pathology to the real world.
Good luck on your exams, good luck on your clinical rotations, and we will catch you on the next deep dive.
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
Using this chapter to study? Last Minute Lecture is free and student-run. If it helped, consider supporting the project.
Support LML ♥Related Chapters
- Care of Patients With Disorders of the Lower Respiratory SystemMedical-Surgical Nursing: Concepts and Practice
- Disorders of Ventilation and Gas ExchangePorth's Pathophysiology: Concepts of Altered Health States
- Alterations of Pulmonary FunctionPathophysiology: The Biologic Basis for Disease in Adults and Children
- Alterations of Pulmonary FunctionUnderstanding Pathophysiology
- Disorders of the Vascular SystemPrimary Care: The Art and Science of Advanced Practice Nursing – an Interprofessional Approach
- Management of Patients with Chest and Lower Respiratory Tract DisordersBrunner & Suddarth’s Textbook of Medical-Surgical Nursing